Interrelated mechanisms in reward and learning

Neurochemistry International

Volumn 52, Issue 1, 2008, Pages 73-79

  Lajtha, Abel ^a,b  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Addiction; Microdialysis; Neurotransmitter changes; Nicotine effects; Receptor antagonists; Reward mechanism

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; ACETYLCHOLINE; AMINO ACID DERIVATIVE; AMPA RECEPTOR; CATECHOLAMINE; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; NICOTINE; NICOTINIC RECEPTOR;

ARTICLE; BRAIN REGION; COGNITION; DRUG DEPENDENCE; FOOD; HIPPOCAMPUS; LEARNING; MEMORY; METABOLITE; NEUROTRANSMITTER RELEASE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; REWARD; STIMULUS RESPONSE; TEMPORAL CORTEX;

ANIMALS; BRAIN; LEARNING; NEUROTRANSMITTER AGENTS; NICOTINE; REWARD;

EID: 36849001359     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.08.019     Document Type: Article

References (46)

1. Abe K., Yamaguchi S., Sugiura M., and Saito H. The ethanol metabolite acetaldehyde inhibits the induction of long-term potentiation in the rat dentate gyrus in vivo. Br. J. Pharmacol. 127 (1999) 1805-1810
2. Abercrombie E.D., Keefe K.A., DiFrischia D.S., and Zigmond M.J. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J. Neurochem. 52 (1989) 1655-1658
3. 2+o-independent veratridine-evoked acetylcholine release from striatal slices is not inhibited by vesamicol (AH5183): mobilization of distinct transmitter pools. J. Neurochem. 56 (1991) 52-58
4. Adinoff B. Neurobiologic processes in drug reward and addiction. Harv. Rev. Psychiatry 12 (2004) 305-320
5. Berrettini W.H., and Lerman C.E. Pharmacotherapy and pharmacogenetics of nicotine dependence. Am. J. Psychiatry 162 (2005) 1441-1451
6. Chaudhri N., Caggiula A.R., Donny E.C., Palmatier M.I., Liu X., and Sved A.F. Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology (Berl) 184 (2006) 353-366
7. Di Chiara G., and Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A 85 (1988) 5274-5278
8. Di Chiara G., Bassareo V., Fenu S., De Luca M.A., Spina L., Cadoni C., Acquas E., Carboni E., Valentini V., and Lecca D. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 47 Suppl. 1 (2004) 227-241
9. Doherty M., and Gratton A. Differential involvement of ventral tegmental GABA(A) and GABA(B) receptors in the regulation of the nucleus accumbens dopamine response to stress. Brain Res. 1150 (2007) 62-68
10. Erhardt S., Schwieler L., and Engberg G. Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine. Synapse 43 (2002) 227-237
11. Fagerstrom K., and Balfour D.J. Neuropharmacology and potential efficacy of new treatments for tobacco dependence. Expert. Opin. Invest. Drugs 15 (2006) 107-116
12. Fallon S., Shearman E., Sershen H., and Lajtha A. The Effects of Glutamate and GABA Receptor Antagonists on Nicotine-induced Neurotransmitter Changes in Cognitive Areas. Neurochem. Res. 32 (2007) 535-553
13. Fallon, S., Shearman, E., Sershen, H., Lajtha, A., 2007b. Food reward-induced neurotransmitter changes in cognitive brain regions. Neurochem. Res. 32, in press.
14. Gahring L.C., and Rogers S.W. Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells. AAPS J. 7 (2005) E885-E894
15. Gotti C., Moretti M., Bohr I., Ziabreva I., Vailati S., Longhi R., Riganti L., Gaimarri A., McKeith I.G., Perry R.H., Aarsland D., Larsen J.P., Sher E., Beattie R., Clementi F., and Court J.A. Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation. Neurobiol. Dis. 23 (2006) 481-489
16. Hukkanen J., Jacob III P., and Benowitz N.L. Metabolism and disposition kinetics of nicotine. Pharmacol. Rev. 57 (2005) 79-115
17. Hyman S.E., Malenka R.C., and Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 29 (2006) 565-598
18. Kalivas P.W., and Duffy P. Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res. 675 (1995) 325-328
19. Kenny P.J., and Markou A. Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity. Neuropsychopharmacology 31 (2006) 1203-1211
20. Kreek M.J., LaForge K.S., and Butelman E. Pharmacotherapy of addictions. Nat. Rev. Drug Discov. 1 (2002) 710-726
21. Lecca D., Cacciapaglia F., Valentini V., Gronli J., Spiga S., and Di Chiara G. Preferential increase of extracellular dopamine in the rat nucleus accumbens shell as compared to that in the core during acquisition and maintenance of intravenous nicotine self-administration. Psychopharmacology (Berl) 184 (2006) 435-446
22. Levin E.D., McClernon F.J., and Rezvani A.H. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) 184 (2006) 523-539
23. Mameli-Engvall M., Evrard A., Pons S., Maskos U., Svensson T.H., Changeux J.P., and Faure P. Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron 50 (2006) 911-921
24. Marinelli S., Pascucci T., Bernardi G., Puglisi-Allegra S., and Mercuri N.B. Activation of TRPV1 in the VTA excites dopaminergic neurons and increases chemical- and noxious-induced dopamine release in the nucleus accumbens. Neuropsychopharmacology 30 (2005) 864-870
25. Maskos U. Emerging concepts: novel integration of in vivo approaches to localize the function of nicotinic receptors. J. Neurochem. 100 (2007) 596-602
26. Naftchi N.E., Maker H., Lapin E., Sleis J., Lajtha A., and Leeman S. Acute reduction of brain substance P induced by nicotine. Neurochem. Res. 13 (1988) 305-309
27. Pezze M.A., and Feldon J. Mesolimbic dopaminergic pathways in fear conditioning. Prog. Neurobiol. 74 (2004) 301-320
28. Pierce R.C., and Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?. Neurosci. Biobehav. Rev. 30 (2006) 215-238
29. Quertemont E., Tambour S., Bernaerts P., Zimatkin S.M., and Tirelli E. Behavioral characterization of acetaldehyde in C57BL/6J mice: locomotor, hypnotic, anxiolytic and amnesic effects. Psychopharmacology (Berl) 177 (2004) 84-92
30. Quertemont E., Tambour S., and Tirelli E. The role of acetaldehyde in the neurobehavioral effects of ethanol: a comprehensive review of animal studies. Prog. Neurobiol. 75 (2005) 247-274
31. Reilly M.A., Lapin E.P., Maker H.S., and Lajtha A. Chronic nicotine administration increases binding of [3H]domperidone in rat nucleus accumbens. J. Neurosci. Res. 18 (1987) 621-625
32. Rossi S., Singer S., Shearman E., Sershen H., and Lajtha A. Regional heterogeneity of nicotine effects on neurotransmitters in rat brains in vivo at low doses. Neurochem. Res. 30 (2005) 91-103
33. Rossi S., Singer S., Shearman E., Sershen H., and Lajtha A. The effects of cholinergic and dopaminergic antagonists on nicotine-induced cerebral neurotransmitter changes. Neurochem. Res. 30 (2005) 541-558
34. Salamone J.D., Correa M., Mingote S.M., and Weber S.M. Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. Curr. Opin. Pharmacol. 5 (2005) 34-41
35. Schnoll R.A., and Lerman C. Current and emerging pharmacotherapies for treating tobacco dependence. Expert. Opin. Emerg. Drugs 11 (2006) 429-444
36. Shearman E., Rossi S., Sershen H., Hashim A., and Lajtha A. Locally administered low nicotine-induced neurotransmitter changes in areas of cognitive function. Neurochem. Res. 30 (2005) 1055-1066
37. Singer S., Rossi S., Verzosa S., Hashim A., Lonow R., Cooper T., Sershen H., and Lajtha A. Nicotine-induced changes in neurotransmitter levels in brain areas associated with cognitive function. Neurochem. Res. 29 (2004) 1779-1792
38. Singh A., Potter A., and Newhouse P. Nicotinic acetylcholine receptor system and neuropsychiatric disorders. IDrugs 7 (2004) 1096-1103
39. Svenningsson P., Nairn A.C., and Greengard P. DARPP-32 mediates the actions of multiple drugs of abuse. AAPS J. 7 (2005) E353-E360
40. Sziraki I., Sershen H., Benuck M., Hashim A., and Lajtha A. Receptor systems participating in nicotine-specific effects. Neurochem. Int. 33 (1998) 445-457
41. Sziraki I., Lipovac M.N., Hashim A., Sershen H., Allen D., Cooper T., Czobor P., and Lajtha A. Differences in nicotine-induced dopamine release and nicotine pharmacokinetics between Lewis and Fischer 344 rats. Neurochem. Res. 26 (2001) 609-617
42. Sziraki I., Sershen H., Hashim A., and Lajtha A. Receptors in the ventral tegmental area mediating nicotine-induced dopamine release in the nucleus accumbens. Neurochem. Res. 27 (2002) 253-261
43. Todorov L., Windisch K., Shersen H., Lajtha A., Papasova M., and Vizi E.S. Prejunctional nicotinic receptors involved in facilitation of stimulation-evoked noradrenaline release from the vas deferens of the guinea-pig. Br. J. Pharmacol. 102 (1991) 186-190
44. Toth E., Sershen H., Hashim A., Vizi E.S., and Lajtha A. Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid. Neurochem. Res. 17 (1992) 265-271
45. Toth E., Vizi E.S., and Lajtha A. Effect of nicotine on levels of extracellular amino acids in regions of the rat brain in vivo. Neuropharmacology 32 (1993) 827-832
46. van Erp A.M., and Miczek K.A. Aggressive behavior, increased accumbal dopamine, and decreased cortical serotonin in rats. J. Neurosci. 20 (2000) 9320-9325